Policy | December 03, 2025
US & UK reach historic pharma pricing pact
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
This is in pursuance to the announcement made in the Union Budget for the year 2024-25 exempting these three anti-cancer medicines from customs duty
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
To mark the occasion, Integrated Pharmaceutical Database Management System 2.0 (IPDMS 2.0), an integrated responsive cloud-based application developed by NPPA with technical support from C-DAC will be launched
The vaccines are currently only authorised for emergency use in the country
A total of 12 generic medicines have been included in the list
Subscribe To Our Newsletter & Stay Updated
